1. Ahn, J.H., Jang, W.J., and Hayward, G.S. 1999. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol. 73, 10458–10471.
2. Arvin, A.M. and Gilden, D. 2013 Varicellar-zoster virus, pp. 2015–2184. In Knipe, D.M., Howley, P.M., Cohen, J.I., Griffin, D.E., Lamb, R.A., Martin, M.A., Racaniello, V.R., and Roizmanm, B. (eds.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA, USA.
3. Baudoux, L., Defechereux, P., Schoonbroodt, S., Merville, M.P., Rentier, B., and Piette, J. 1995. Mutational analysis of varicellazoster virus major immediate-early protein IE62. Nucleic Acids Res. 23, 1341–1349.
4. CDC. 1996. Center for disease control and prevention. Establishment of VARIVAX pregnancy registry. MMWR Morb. Mortal. Wkly. Rep. 45, 239.
5. Cilloniz, C., Jackson, W., Grose, C., Czechowski, D., Hay, J., and Ruyechan, W.T. 2007. The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator. J. Virol. 81, 761–774.